Kyowa Kirin International plc.
Sarah McDonald-Barker's work experience begins with their role as a Corporate Communications Director, International Corporate Affairs at Kyowa Kirin International plc. starting in June 2023. Prior to this, they worked as a Senior Director, Healthcare Communications at BCW Global from March 2022 to March 2023. Sarah also has experience at Pfizer, where they held various roles including Global Strategy and Communications Director (February 2021 to April 2022), Communications and Operations Director (May 2018 to February 2021), and Digital Communications Lead (November 2016 to May 2018). Sarah also worked as an Account Director at HAVAS LYNX from June 2015 to November 2016. Before that, they were an Account Manager at 23red from June 2013 to June 2015. Sarah's earlier work experience includes roles as a Regional International Account Manager at IPGMEDIA from May 2012 to June 2013, a Social Marketing and Communications Officer at the Australian Organ & Tissue Donation & Transplantation Authority from June 2011 to March 2012, and a Health Promotion and Marketing professional at the Australian Medicare Local Alliance from January 2010 to June 2011. Their earliest recorded work experience is in Financial and Portfolio Administration at RBS Amro Morgans from an unspecified start date to 2010.
Sarah McDonald-Barker has a Bachelor of Arts (B.A.) degree in Pharmacology, Cultural Studies, and Art History from the University of Sydney, which they obtained from 2006 to 2008. Sarah then pursued a Master's degree in Media & Journalism at the same university from 2008 to 2009. In 2017, they attended the University of Cambridge and earned a Certificate in Creative Writing. Currently, they are studying Public Policy Economics and is expected to graduate with a Certificate from the University of Oxford in 2021.
This person is not in any teams
This person is not in any offices
Kyowa Kirin International plc.
At Kyowa Kirin International (KKI), commitment to life is at our core. We strive to answer the unmet medical needs of patients, their families, and the medical professionals who care for them. With more than 700 people focused on this purpose, we are a rapidly growing specialty biopharmaceutical company, engaged in the development and commercialisation of innovative medicines in the therapy areas of oncology, nephrology and central nervous system (CNS) across Europe and the Middle East. KKI, headquartered in Marlow, England, and Galashiels, Scotland, is owned by Kyowa Kirin Co., Ltd (KKC), of Japan. Founded in 1949, KKC has a successful track record in Japan and has expanded globally. Our history of innovation is built on a strong legacy of scientific discovery and fostering collaborations that accelerate the delivery of innovative medicines to patients. Grounded in our expertise in antibody engineering, we continue to investigate new molecules with the potential to contribute to the future of healthcare and make a difference in the lives of patients. At KKI, it is our people who have helped make a real difference to our success. Working together, our employees excel in achieving results quickly and effectively, bringing diverse and unique viewpoints to the company to achieve our vision. Our passion and energy around our core values of commitment to life, innovation, integrity and teamwork help ensure that every day, each of us is focused on not just making medicines, but also making people smile. With our strong legacy and exciting future, KKI is looking for great people to join our team and support our commitment to life.